Drug Delivery Systems for the Treatment of Ischemic Stroke

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pharmaceutical Research

• Publication date

  2013-01-10

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1007/s11095-012-0959-2PMID 23307348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RITA LEVI-MONTALCINI : The Path to the Discovery of Nerve Growth Factor

  2014cited by this paper
• Effects of stromal cell-derived factor 1α delivered at different phases of transient focal ischemia in rats.

  2012cited by this paper
• Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.

  2012cited by this paper
• Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway.

  2012cited by this paper
• Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound.

  2012cited by this paper
• An Antagomir to MicroRNA Let7f Promotes Neuroprotection in an Ischemic Stroke Model

  2012cited by this paper
• Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain.

  2012cited by this paper
• The box a domain of high mobility group box‐1 protein as an efficient siRNA carrier with anti‐inflammatory effects

  2012cited by this paper
• Physicochemical and physiological considerations for efficient nose-to-brain targeting

  2012cited by this paper
• Dexamethasone-loaded peptide micelles for delivery of the heme oxygenase-1 gene to ischemic brain.

  2012cited by this paper
• Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury.

  2012cited by this paper
• Intranasal delivery of biologics to the central nervous system.

  2012cited by this paper
• Nanoerythropoietin Is 10-Times More Effective Than Regular Erythropoietin in Neuroprotection in a Neonatal Rat Model of Hypoxia and Ischemia

  2012cited by this paper
• Ultrasound-induced blood-brain barrier opening.

  2012cited by this paper
• Optimization of the Ultrasound-Induced Blood-Brain Barrier Opening

  2012cited by this paper
• Targeted Over-Expression of Glutamate Transporter 1 (GLT-1) Reduces Ischemic Brain Injury in a Rat Model of Stroke

  2011cited by this paper
• Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone.

  2011cited by this paper
• Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats.

  2011cited by this paper
• Experimental and clinical application of plasmid DNA in the field of central nervous diseases.

  2011cited by this paper
• rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model.

  2011cited by this paper
• The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain.

  2011cited by this paper
• Transport of epidermal growth factor in the stroke-injured brain.

  2011cited by this paper
• Neuroprotection for ischemic stroke: Two decades of success and failure

  2011cited by this paper
• Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing

  2011cited by this paper
• Overexpression of netrin-1 improves neurological outcomes in mice following transient middle cerebral artery occlusion

  2011cited by this paper
• Postacute Ischemia Vascular Endothelial Growth Factor Transfer by Transferrin-Targeted Liposomes Attenuates Ischemic Brain Injury After Experimental Stroke in Rats

  2011cited by this paper
• Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain.

  2011influential reference
• Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.

  2010cited by this paper
• HPMA copolymers for masking and retargeting of therapeutic viruses.

  2010cited by this paper
• Therapeutic effects of a reducible poly (oligo-D-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury.

  2010cited by this paper
• Intracellular transduction using cell-penetrating peptides.

  2010cited by this paper
• Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.

  2010cited by this paper
• Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury.

  2010cited by this paper
• Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT)

  2010cited by this paper
• Injectable VEGF Hydrogels Produce Near Complete Neurological and Anatomical Protection following Cerebral Ischemia in Rats

  2010cited by this paper
• Mitochondria, oxidative metabolism and cell death in stroke.

  2010cited by this paper
• Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Therapy Using the Oxygen-Dependent Degradation Domain in Myocardial Ischemia

  2010cited by this paper
• The blood-brain barrier in brain homeostasis and neurological diseases.

  2009cited by this paper
• Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection

  2009cited by this paper
• Viral vector approaches to modify gene expression in the brain.

  2009influential reference
• Viral vectors: from virology to transgene expression

  2009influential reference
• Protective Effect of Post-Ischaemic Viral Delivery of Heat Shock Proteins in vivo

  2009cited by this paper
• TAT-Hsp70-Mediated Neuroprotection and Increased Survival of Neuronal Precursor Cells after Focal Cerebral Ischemia in Mice

  2009cited by this paper
• Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury

  2009influential reference
• Innate Immune Recognition of Viruses and Viral Vectors

  2009cited by this paper
• Fenofibrate-loaded PLGA microparticles: effects on ischemic stroke.

  2009cited by this paper
• Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.

  2009cited by this paper
• GDNF fusion protein for targeted‐drug delivery across the human blood–brain barrier

  2008influential reference
• Ultrasound-enhanced drug and gene delivery: A review

  2008cited by this paper
• Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway.

  2008cited by this paper
• Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic.

  2008cited by this paper
• Stroke.

  2008cited by this paper
• Early Release of HMGB-1 from Neurons after the Onset of Brain Ischemia

  2008cited by this paper
• Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.

  2008cited by this paper
• Induction and subcellular localization of high‐mobility group box–1 (HMGB1) in the postischemic rat brain

  2008cited by this paper
• Del-1 gene transfer induces cerebral angiogenesis in mice.

  2008cited by this paper
• Innate Immune Response to Adenoviral Vectors Is Mediated by both Toll-Like Receptor-Dependent and -Independent Pathways

  2007cited by this paper
• Postischemic Gene Transfer of Soluble Flt-1 Protects against Brain Ischemia with Marked Attenuation of Blood—Brain Barrier Permeability

  2007cited by this paper
• Molecular targets in cerebral ischemia for developing novel therapeutics.

  2007cited by this paper
• Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury

  2007cited by this paper
• Transvascular delivery of small interfering RNA to the central nervous system

  2007cited by this paper
• Long-Lasting Regeneration After Ischemia in the Cerebral Cortex

  2007cited by this paper
• Humanization of anti‐human insulin receptor antibody for drug targeting across the human blood–brain barrier

  2007cited by this paper
• Gene therapy using SOD1 protects striatal neurons from experimental stroke.

  2007cited by this paper
• Neuroprotective effects of the novel polyethylene glycol-hemoglobin conjugate SB1 on experimental cerebral thromboembolism in rats.

  2007cited by this paper
• Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability

  2007cited by this paper
• A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats.

  2007cited by this paper
• Dexamethasone-conjugated low molecular weight polyethylenimine as a nucleus-targeting lipopolymer gene carrier.

  2007cited by this paper
• Vascular permeability in ocular disease and the role of tight junctions

  2007cited by this paper
• Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.

  2007cited by this paper
• PPARs in the brain.

  2007cited by this paper
• Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

  2006cited by this paper
• Kallikrein Protects Against Ischemic Stroke by Inhibiting Apoptosis and Inflammation and Promoting Angiogenesis and Neurogenesis

  2006cited by this paper
• Products of heme oxygenase and their potential therapeutic applications.

  2006cited by this paper
• PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.

  2006cited by this paper
• Intracerebral Infusion of Glial Cell Line–Derived Neurotrophic Factor Promotes Striatal Neurogenesis After Stroke in Adult Rats

  2006cited by this paper
• Adeno-Associated Viral Vector-Mediated Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Expression Attenuates Ischemic Brain Injury After Focal Cerebral Ischemia in Mice

  2006cited by this paper
• Glial Cell Line-Derived Neurotrophic Factor Family Members Sensitize Nociceptors In Vitro and Produce Thermal Hyperalgesia In Vivo

  2006cited by this paper
• HMGB1, a Novel Cytokine-Like Mediator Linking Acute Neuronal Death and Delayed Neuroinflammation in the Postischemic Brain

  2006influential reference
• Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2006cited by this paper
• Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions

  2006cited by this paper
• Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg.

  2006cited by this paper
• Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.

  2006cited by this paper
• Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system.

  2005influential reference
• I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

  2005influential reference
• Antisense strategies for oncogene inactivation.

  2005cited by this paper
• Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils

  2004cited by this paper
• Infiltrating Macrophages as In Vivo Targets for Intravenous Gene Delivery in Cerebral Infarction

  2004cited by this paper
• Targets for Vascular Protection After Acute Ischemic Stroke

  2004cited by this paper
• Kallikrein Gene Transfer Protects Against Ischemic Stroke by Promoting Glial Cell Migration and Inhibiting Apoptosis

  2004cited by this paper
• Recombinant Adeno-Associated Virus As Delivery Vector for Gene Therapy—A Review

  2004cited by this paper
• Development of new drugs in angiogenesis.

  2004cited by this paper
• Sp1-Dependent Regulation of the RTP801 Promoter and Its Application to Hypoxia-Inducible VEGF Plasmid for Ischemic Disease

  2004cited by this paper
• Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.

  2004cited by this paper
• Blood pressure in acute intracerebral haemorrhage

  2004cited by this paper
• Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus

  2004cited by this paper
• Adrenomedullin Gene Delivery Protects Against Cerebral Ischemic Injury by Promoting Astrocyte Migration and Survival

  2004cited by this paper
• The role of Bcl-2 family members in tumorigenesis.

  2004cited by this paper
• Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative Diseases

  2003cited by this paper
• Intravenous TAT-GDNF Is Protective After Focal Cerebral Ischemia in Mice

  2003cited by this paper

• Secretome from Uterine Cervical Mesenchymal Stem Cells as a Protector of Neuronal Cells Against Oxidative Stress and Inflammation

  2025cites this paper
• Engineered extracellular vesicles for nose-to-brain co-delivery of chlorotoxin and curcumin for treatment of glioblastoma.

  2025cites this paper
• A macro-transection model of brain trauma for neuromaterial testing with functional electrophysiological readouts

  2025cites this paper
• Nucleus targeting-functionalized cell-membrane nanovesicles for intranasal delivery of therapeutic plasmid DNA into the brain for the treatment of glioblastoma

  2025cites this paper
• Advances in Engineered Nanoparticles for the Treatment of Ischemic Stroke by Enhancing Angiogenesis

  2024cites this paper
• Lipid nanoparticle-mediated drug delivery to the brain.

  2023cites this paper
• Ultrasound trapping and navigation of microrobots in the mouse brain vasculature

  2023cites this paper
• VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases

  2023influential citation
• Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia/reperfusion injury mice inhibiting neuron ferroptosis

  2023cites this paper
• Acoustic trapping and navigation of microrobots in the mouse brain vasculature

  2023cites this paper
• Small interfering RNAs based therapies for intracerebral hemorrhage: challenges and progress in drug delivery systems

  2022cites this paper
• Delivery of self-replicating messenger RNA into the brain for the treatment of ischemic stroke.

  2022cites this paper
• Targeted delivery of edaravone by liposomes for the treatment of ischemic stroke.

  2022cites this paper
• Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model.

  2021cites this paper
• Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment

  2021cites this paper
• Leveraging Electrostatic Interactions for Drug Delivery to the Joint

  2020cites this paper
• Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine

  2020cites this paper
• MSC-exosomes in regenerative medicine

  2020cites this paper
• Messenger RNA/polymeric carrier nanoparticles for delivery of heme oxygenase-1 gene in the post-ischemic brain.

  2020cites this paper
• Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia.

  2019cites this paper
• Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.

  2019cites this paper
• Perlecan regulates pericyte dynamics in the maintenance and repair of the blood–brain barrier

  2019cites this paper
• Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study.

  2019cites this paper
• Intranasal Delivery of Therapeutic Peptides for Treatment of Ischemic Brain Injury

  2019cites this paper
• Therapeutic Potential of Intranasal Drug Delivery in Preclinical Studies of Ischemic Stroke and Intracerebral Hemorrhage

  2019cites this paper
• Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy.

  2018cites this paper
• Pre-stroke surgery is not beneficial to normotensive rats undergoing sixty minutes of transient focal cerebral ischemia

  2018cites this paper
• Drug delivery systems for programmed and on‐demand release☆

  2018cites this paper
• Role of caveolin-1/vascular endothelial growth factor pathway in basic fibroblast growth factor-induced angiogenesis and neurogenesis after treadmill training following focal cerebral ischemia in rats.

  2017cites this paper
• Deoxycholic Acid-Conjugated Polyethylenimine for Delivery of Heme Oxygenase-1 Gene in Rat Ischemic Stroke Model.

  2017cites this paper
• Estudio del transporte de sustancias a través de la barrera hematoencefálica mediante el anticuerpo 8D3 dirigido contra el receptor de transferrina

  2017cites this paper
• Brain Drug Delivery Systems for the Stroke Intervention and Recovery.

  2017cites this paper
• Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model.

  2016cites this paper
• Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model

  2016cites this paper
• Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil.

  2016cites this paper
• Targeted delivery of growth factors in ischemic stroke animal models

  2016cites this paper
• Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases

  2016influential citation
• Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles.

  2016cites this paper
• VEGF mimic peptides: Potential applications in central nervous system therapeutics

  2016cites this paper
• Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.

  2015cites this paper
• Encapsulation of VEGF165 into magnetic PLGA nanocapsules for potential local delivery and bioactivity in human brain endothelial cells.

  2015cites this paper
• Brain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.

  2015cites this paper
• Bisphenol A exposure pathways in early childhood: Reviewing the need for improved risk assessment models

  2015cites this paper
• Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage

  2015cites this paper
• Targeting Therapeutics Across the Blood Brain Barrier (BBB), Prerequisite Towards Thrombolytic Therapy for Cerebrovascular Disorders—an Overview and Advancements

  2015cites this paper
• Effects of mesenchymal stem cell therapy, in association with pharmacologically active microcarriers releasing VEGF, in an ischaemic stroke model in the rat.

  2015cites this paper
• Human mesenchymal stem cell loading as a novel targeting and drug delivery system for stroke.

  2015cites this paper
• Mechanisms of Improving Collateral Blood Flow During Ischemic Stroke

  2014cites this paper
• Niosomes of Ascorbic Acid and α-Tocopherol in the Cerebral Ischemia-Reperfusion Model in Male Rats

  2014cites this paper
• Afecciones neurológicas y barrera hematoencefálica. Limitaciones y estrategias para la liberación de fármacos al cerebro

  2014cites this paper
• [Neurological disorders and the blood-brain barrier. Strategies and limitations for drug delivery to the brain].

  2014cites this paper
• Polysaccharides from Angelica sinensis alleviate neuronal cell injury caused by oxidative stress

  2014cites this paper